Next Article in Journal
The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
Next Article in Special Issue
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy
Previous Article in Journal
Progress in Bioengineering Strategies for Heart Regenerative Medicine
Previous Article in Special Issue
A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2022, 23(7), 3484; https://doi.org/10.3390/ijms23073484
Action Date Notes Link
article pdf uploaded. 23 March 2022 12:44 CET Version of Record https://www.mdpi.com/1422-0067/23/7/3484/pdf-vor
article supplementary file uploaded. 23 March 2022 12:44 CET - https://www.mdpi.com/1422-0067/23/7/3484#supplementary
article xml file uploaded 24 March 2022 10:18 CET Original file -
article xml uploaded. 24 March 2022 10:18 CET Update https://www.mdpi.com/1422-0067/23/7/3484/xml
article pdf uploaded. 24 March 2022 10:18 CET Updated version of record https://www.mdpi.com/1422-0067/23/7/3484/pdf
article html file updated 24 March 2022 10:20 CET Original file -
article supplementary file uploaded. 24 March 2022 10:45 CET - https://www.mdpi.com/1422-0067/23/7/3484#supplementary
article html file updated 24 March 2022 10:46 CET Update -
article html file updated 1 August 2022 07:10 CEST Update https://www.mdpi.com/1422-0067/23/7/3484/html
Back to TopTop